Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 17, 2026

Finance Chiefs to Consider World Order After Trump-Xi Reset

View original at finance.yahoo.com
Finance Chiefs to Consider World Order After Trump-Xi Reset (Bloomberg) -- The lopsided foundations of world growth will command the attention of global finance ministers this week in the aftermath of the summit that attempted to reset trade ties between the two biggest economies…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • China agreed with the US to lower levies on some products to promote bilateral trade, underscoring that ties between the world's two largest economies are further stabilizing.

    60% confidence
  • The G7 is a rare forum where Europeans and the US can still have meaningful discussions.

    60% confidence
  • G7 diagnosis can help start a collaborative strategy, but no one expects a G7 statement condemning global imbalances to be enthusiastically adopted by China leading to agreed solutions; however, having solutions on the table is useful.

    60% confidence
  • Economists see the seeds of a more systemic crisis without a concerted effort to re-balance financial and trade flows.

    60% confidence
  • The G20's nebulous divisions may already herald its end.

    60% confidence
  • French officials warn that failure to get beyond short-term issues and grapple with deeper structural mismatches means tensions will only build.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com